Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes

Diabetes, Obesity and Metabolism

Volumn 15, Issue 6, 2013, Pages 558-563

  Dungan, K M ^a   Osei, K ^a   Sagrilla, C ^b   Binkley, P ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Autonomic tone; Glycaemic variability; Inpatient; Intravenous insulin

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETIC PATIENT; DRUG EFFECT; FEMALE; GLYCEMIC CONTROL; HEART RATE VARIABILITY; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; IMPEDANCE CARDIOGRAPHY; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PARASYMPATHETIC TONE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SYMPATHETIC TONE;

EID: 84877616350     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12069     Document Type: Article

References (45)

1. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-252.
2. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia. Hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118: 173-179.
3. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008-3013.
4. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38: 838-842.
5. Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003; 26: 1485-1489.
6. Niskanen L, Virkamäki A, Hansen JB, Saukkonen T. Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: evidence from the PREDICTIVE study. Diabetes Res Clin Pract 2009; 86: e15-e18.
7. Dungan KM, Braithwaite SS, Preiser J. Stress hyperglycemia. Lancet 2009; 373: 1798-1807.
8. Egi M, Bellomo R, Stachowski E et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011; 39: 105-111.
9. Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM. Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Clin Endocrinol 2004; 60: 451-456.
10. Moghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists, American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15: 353-369.
11. Umpierrez GE, Hellman R, Korytkowski MT et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. Endocrine Society. J Clin Endocrinol Metab 2012; 97: 16-38.
12. Cacioppo JT, Berntson GG, Binkley PF, Quigley KS, Uchino BN, Fieldstone A. Autonomic cardiac control II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology 1994; 31: 586-598.
13. Schroeder EB, Chambless LE, Liao D et al. Atherosclerosis Risk in Communities (ARIC) study. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005; 28: 668-674.
14. Pop-Busui R, Evans GW, Gerstein HC et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33: 1578-1584.
15. Santini V, Ciampittiello G, Gigli F et al. QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA. Nutr Metab Cardiovasc Dis 2007; 17: 712-718.
16. Koivikko ML, Salmela PI, Airaksinen KE et al. Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type 1 diabetes. Diabetes 2005; 54: 744-750.
17. Newlin DB, Levenson RW. Pre-ejection period: measuring beta-adrenergic influences upon the heart. Psychophysiology 1979; 16: 546-553.
18. Harris WS, Schoenfeld CD, Weissler AM. Effects of adrenergic receptor activation and blockade on the systolic preejection period, heart rate, and arterial pressure in man. J Clin Invest 1967; 46: 1704-1714.
19. Billman GE. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training. Am J Physiol Heart Circ Physiol 2009; 297: H1171-H1193.
20. Licht CM, Vreeburg SA, van Reedt Dortland AK et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010; 95: 2458-2466.
21. Umpierrez GE, Smiley D, Jacobs S et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011; 34: 256-261.
22. Goldberg PA. Memoirs of a root canal salesman: the successful implementation of a hospital-wide intravenous insulin infusion protocol. Endocr Pract 2006; 12(Suppl. 3): 79-85.
23. Lunetta M, Le Moli R, Grasso G, Sangiorgio L. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 1998; 39: 165-172.
24. Sherwood A, Allen MT, Fahrenberg J, Kelsey RM, Lovallo WR, Van Doornen LJ. Methodological guidelines for impedance cardiography. Psychophysiology 1990; 27: 1-23.
25. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065.
26. Berntson GG, Bigger JT Jr, Eckberg DL et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997; 34: 623-648.
27. Ryan EA, Shandro T, Green K et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955-962.
28. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005; 7: 253-263.
29. Zijlstra E, Heise T, Nosek L, Heinemann L, Heckermann S. Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab 2012; 15: 130-135.
30. Taborsky GJ Jr, Mundinger TO. Minireview: the role of the autonomic nervous system in mediating the glucagon response to hypoglycemia. Endocrinology 2012; 153: 1055-1062.
31. Adler GK, Bonyhay I, Failing H, Waring E, Dotson S, Freeman R. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes 2009; 58: 360-366.
32. Kammler D. A First Course in Fourier Analysis. Upper Saddle River: Prentice Hall, 2000.
33. Braithwaite SS. Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence. Curr Diab Rep 2013; 13: 138-154.
34. Ali NA, O'Brien JM, Dungan K et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36: 2316-2321.
35. Dungan KM, Binkley P, Nagaraja HN, Schuster DS, Osei K. Assessment of glycemic control and variability in patients hospitalized with congestive heart failure during the implementation of hospital-wide initiatives and effects on mortality. Diabetes Metab Res Rev 2011; 27: 85-93.
36. Zuo YY, Kang Y, Yin WH, Wang B, Chen Y. The association of mean glucose level and glucose variability with intensive care unit mortality in patients with severe acute pancreatitis. J Crit Care 2012; 27: 146-152.
37. Meynaar IA, Eslami S, Abu-Hanna A, van der Voort P, de Lange DW, de Keizer N. Blood glucose amplitude variability as predictor for mortality in surgical and medical intensive care unit patients: a multicenter cohort study. J Crit Care 2012; 27: 119-124.
38. Curtis BM, O'Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002; 77: 45-54.
39. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
40. Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 2010; 90: 513-557.
41. Adamson PB, Huang MH, Vanoli E, Foreman RD, Schwartz PJ, Hull SS. Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. Circulation 1994; 90: 976-982.
42. Dungan KM, Gavrilina T, Hall C, Lorenzo A, Schuster D. Safety and efficacy of a universal nursing-run intravenous insulin guideline on medical and surgical wards. (Poster 2804ADA11D1) ADA 71st Annual Scientific Sessions, 2011, San Diego, CA.
43. Dungan K, Hall C, Schuster D, Osei K. Comparison of 3 algorithms for Basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery. Endocr Pract 2011; 17: 753-758.
44. Lovig KO, Horwitz L, Lipska K, Kosiborod M, Krumholz HM, Inzucchi SE. Discontinuation of antihyperglycemic therapy after acute myocardial infarction: medical necessity or medical error? Jt Comm J Qual Patient Saf 2012; 38: 403-407.
45. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-982.